Immutep Announces Second Japanese Patent Grant for LAG-3 Antagonist Antibody LAG525

Friday, March 18, 2022 1 min read

Key Takeaway: Immutep Announces Second Japanese Patent Grant for LAG-3 Antagonist Antibody LAG525

Full Press Release Details

Immutep Announces Second Japanese Patent Grant for LAG-3 Antagonist Antibody LAG525.